Patents by Inventor Kenneth Duchin

Kenneth Duchin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
    Publication number: 20070060635
    Abstract: A method of increasing the bioavailability upon oral administration of a pharmacologically active target agent, particularly an antitumor or antineoplastic agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide), comprises the oral co-administration to a mammalian patient of the target agent and an oral bioavailability-enhancing agent (e.g., cyclosporin A, cyclosporin D, cyclosporin F or ketoconazole). The enhancing agent may be administered orally from 0.5-24 hrs. prior to the oral administration of one or more doses of the target agent, substantially simultaneously with the target agent or both prior to and substantially simultaneously with the target agent.
    Type: Application
    Filed: August 14, 2006
    Publication date: March 15, 2007
    Applicant: Teva North America
    Inventors: Samuel Broder, Kenneth Duchin, Sami Selim
  • Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
    Publication number: 20050238634
    Abstract: A method of increasing the bioavailability upon oral administration of a pharmacologically active target agent, particularly an antitumor or antineoplastic agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide), comprises the oral co-administration to a mammalian patient of the target agent and an oral bioavailability-enhancing agent (e.g., cyclosporin A, cyclosporin D, cyclosporin F or ketoconazole). The enhancing agent may be administered orally from 0.5-24 hrs. prior to the oral administration of one or more doses of the target agent, substantially simultaneously with the target agent or both prior to and substantially simultaneously with the target agent.
    Type: Application
    Filed: April 13, 2005
    Publication date: October 27, 2005
    Applicant: Baker Norton Pharmaceuticals, Inc.
    Inventors: Samuel Broder, Kenneth Duchin, Sami Selim